Back to VA VANGUARD CAPITAL MANAGEMENT LLC
NVCT2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in NUVECTIS PHARMA INC
Yes. Vanguard Capital Management holds 872,482 shares of NVCT (Nuvectis Pharma), worth $16M, as of its Q2 2026 13F filing. It increased the position by 212,603 shares (+32.2%) from Q1 2026. Vanguard Capital Management has held NVCT in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$16M
Current Shares
872,482
Total Value Change
+$10.9M
Total Shares Change
+212,603
Quarter-by-Quarter History
Other major holders of NVCT: BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC